Mr Dan Mettler, CRNA | |
11220 338th Ave, Eureka, SD 57437-6801 | |
(605) 577-6240 | |
Not Available |
Full Name | Mr Dan Mettler |
---|---|
Gender | Male |
Speciality | Nurse Anesthetist, Certified Registered |
Location | 11220 338th Ave, Eureka, South Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952525966 | NPI | - | NPPES |
3802 | Other | ND | CRNA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | R26023 (North Dakota) | Secondary |
367500000X | Nurse Anesthetist, Certified Registered | R020291 (South Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Dan Mettler, CRNA 11220 338th Ave, Eureka, SD 57437-6801 Ph: (605) 577-6240 | Mr Dan Mettler, CRNA 11220 338th Ave, Eureka, SD 57437-6801 Ph: (605) 577-6240 |
News Archive
The number of Valley Fever cases in California rose to a record level in 2016, with 5,372 reported — a jump of 71 percent from the previous year. Historically, about three-quarters of cases have been in the state's heavily agricultural San Joaquin Valley.
"Seven out of the eight governments in Africa's Sahel ... have taken the unprecedented step of declaring emergencies as 12 million people in the region are threatened by hunger," Inter Press Service reports.
Induced pluripotent stem cells (iPSCs) - adult cells reprogrammed back to an embryonic stem cell-like state-may better model the genetic contributions to each patient's particular disease. In a process called cellular reprogramming, researchers at Icahn School of Medicine at Mount Sinai have taken mature blood cells from patients with myelodysplastic syndrome (MDS) and reprogrammed them back into iPSCs to study the genetic origins of this rare blood cancer.
Coventry, the creator of the secondary market for life insurance in the U.S., applauds the New York Court of Appeals decision in Kramer v. Phoenix Life Insurance Company as a significant victory for life insurance consumers and the secondary market for life insurance.
› Verified 9 days ago